about
Management of EGFR-inhibitor associated rash: a retrospective study in 49 patientsComplement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivoMolecular aspects of thyroid hormone actionsAirway epithelial epidermal growth factor receptor mediates hogbarn dust-induced cytokine release but not Ca2+ responseFAM83A confers EGFR-TKI resistance in breast cancer cells and in miceCetuximab/C225-induced intracellular trafficking of epidermal growth factor receptorEGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistanceAmplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancerEmergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerNimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial originClinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal CancerPredictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of OptionsRole of Receptor Tyrosine Kinase Signaling in Renal FibrosisSelective Sensing of Tyrosine Phosphorylation in Peptides Using Terbium(III) ComplexesMechanisms underlying skin disorders induced by EGFR inhibitorsCurrent Management Strategies in Breast Cancer by Targeting Key Altered Molecular PlayersBiomarkers predicting resistance to epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer with wild-type KRASPharmacologic resistance in colorectal cancer: a reviewClinical efficacy and drug resistance of anti-epidermal growth factor receptor therapy in colorectal cancerSomatic DNA mutation analysis in targeted therapy of solid tumoursThe distinctive nature of adenocarcinoma of the lungCutaneous adverse reactions specific to epidermal growth factor receptor inhibitorsThe Efficacy of Combining EGFR Monoclonal Antibody With Chemotherapy for Patients With Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis From 9 Randomized Controlled TrialsNucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical SensingChloroquine and hydroxychloroquine for cancer therapyThe dynamic nature of the kinomeThe role of systemic treatment before, during, and after definitive treatmentMolecular alterations and biomarkers in colorectal cancerRole of erlotinib in the treatment of non-small cell lung cancer: clinical outcomes in wild-type epidermal growth factor receptor patientsRosacea: The cytokine and chemokine networkGastric Cancer: New Drugs - New StrategiesEpidermal growth factor receptor inhibitors: coming of ageThe Juxtamembrane Region of the EGF Receptor Functions as an Activation DomainMolecular pathology of lung cancer: key to personalized medicine.TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity.EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer.The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of KRAS Status.Tumour biomarkers: homeostasis as a novel prognostic indicator
P2860
Q21195817-08EE475D-0163-47BB-96D8-94A2D90D227BQ21245712-95F2B554-68D1-453F-8DA7-AC1A29B39A95Q22306217-4F11B0B0-F8BB-4949-AD0D-121C148EB924Q23919646-ACC67879-1C9F-4D69-BCD9-D24A4682F043Q24296333-E9CD1C15-EB9C-4477-96E5-B083791F4D50Q24314620-62B5E8DE-583D-4785-A760-57F5C3AE7BD3Q24335999-11B8D613-21F4-401C-9178-47B17D7AAE3BQ24563539-C3C7559D-896C-4166-9EB6-F571FE4387D2Q24604601-457150AF-2CF3-401F-BD17-EA2E055BBC38Q24645217-8DBF1AA3-3AD5-426A-B6F3-2DECCC222229Q26738587-335EB87D-C080-44EA-9EDB-87C52AE08E97Q26738655-31527BE6-11D4-4FA3-8780-0A8967070B66Q26743407-70DA11C8-A7F5-4357-B3F0-6E6272F5292AQ26744839-4A73DDFF-A280-4E2D-94CB-A74ABA4951C8Q26745689-77955406-A9C0-40BF-B4A8-9D4433A9F6FEQ26765877-8344BB41-E994-4AEF-BC38-8C4BCA4B7213Q26766535-88FA28EB-CC7B-412E-A65C-638D35BEE053Q26769850-9A162D87-4F23-4282-867C-C503C33A282EQ26769958-584E32C9-E692-4E97-B32E-EB50BF9BEB9FQ26770324-DBD7B477-323F-4A6C-A734-82D6B503E81BQ26781159-7421F446-CF29-4052-AF1F-19DC2CA8AC71Q26781472-0AE39BDB-2441-466A-94DE-A3A4BE54BA1CQ26796549-87D3E8FD-59AB-4BFC-90F7-295B74191FFAQ26825644-6470FAE5-09C2-4FFC-BA4B-B780383BDFBBQ26827797-968137EE-D8CE-42D4-A8D0-DAA998BB4B55Q26852588-91617512-A682-473D-A9DB-275EBB2120FCQ26859285-2728DAD6-BE3E-4C4F-B788-E9F30076C647Q26862317-6174B960-1FF9-4F55-AF1B-F6009C037520Q26866485-E594DF05-872E-4391-A0E2-E5711ABC7677Q27023344-0B8D4C5E-7EBC-451D-90BA-4D0C1FF8A1FDQ27028079-2184FCB0-2925-400E-98C1-7250552BD3A5Q27030769-DD38BB4B-4AE9-4170-B312-6E7F6584885BQ27646344-B2487EED-1241-45E2-BAD6-F5B087D81369Q27691299-72A3AFF6-D2B3-44E3-B473-39953F938906Q27851543-3F164870-83A7-4B7D-A17D-0A1DCDC0BDD0Q27851583-F4F80D3A-E919-45BA-8476-C39642285177Q27852988-3EA01A6A-3ABA-4138-B36E-A11969F782AFQ27853108-0274060E-4C11-4B6D-8550-B02B56233D44Q27853292-6EE32948-A505-4500-8A58-AA6950BC7CBEQ28069898-E42A4589-2C21-41BD-8628-2A79FEC689F6
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
EGFR antagonists in cancer treatment
@ast
EGFR antagonists in cancer treatment
@en
type
label
EGFR antagonists in cancer treatment
@ast
EGFR antagonists in cancer treatment
@en
prefLabel
EGFR antagonists in cancer treatment
@ast
EGFR antagonists in cancer treatment
@en
P3181
P356
P1476
EGFR antagonists in cancer treatment
@en
P2093
Ciardiello F
P304
P3181
P356
10.1056/NEJMRA0707704
P407
P577
2008-03-01T00:00:00Z